— Know what they know.
Not Investment Advice

LNDZF OTC

Evome Medical Technologies Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -97.6% 3Y: -100.0% 5Y: -99.9%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 52 · $5981 mcap · 60M float · 0.016% daily turnover · Short 84% of daily vol

Balance Sheet Trends

Total Assets
$48M +0.0% ▲
5Y CAGR: +33.5%
Total Liabilities
$44M +0.0% ▲
5Y CAGR: +166.2%
Shareholders Equity
$4M +0.0% ▲
5Y CAGR: -18.4%
Cash & Investments
$919K +0.0% ▲
5Y CAGR: -31.4%
Total Debt
$25M +0.0% ▲
5Y CAGR: +339.8%
Net Debt
$24M +0.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2023
— Assets —
Cash$9M$8M$7M$8M$919K
Short-Term Investments$0$843K$489K$0$0
Cash & ST Investments$9M$9M$8M$8M$919K
Net Receivables$2M$140K$135K$7M$10M
Inventory$0$0$0$5M$10M
Other Current Assets$0$0$0$0$0
Total Current Assets$11M$9M$13M$20M$21M
Property, Plant & Equip.$187K$0$0$5M$13M
Goodwill & Intangibles$0$0$0$17M$13M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$485K$771K
Total Non-Current Assets$187K$0$0$23M$27M
Total Assets$12M$9M$13M$43M$48M
— Liabilities —
Accounts Payable$379K$169K$480K$3M$7M
Short-Term Debt$0$0$0$6M$17M
Deferred Revenue$0$0$0$817K$0
Other Current Liabilities$30K$15K$6M$13M$11M
Total Current Liabilities$409K$367K$6M$23M$38M
Long-Term Debt$0$0$0$5M$257K
Other Non-Current Liab.$0$0$0-$4M$0
Total Non-Current Liabilities$15K$15K$15K$6M$7M
Total Liabilities$409K$367K$6M$30M$44M
— Equity —
Common Stock$31M$31M$31M$39M$54M
Retained Earnings-$24M-$27M-$29M-$33M-$65M
Accumulated OCI$1M$1M$943K$1M$2M
Total Stockholders Equity$11M$9M$7M$13M$4M
Total Liabilities & Equity$12M$9M$13M$43M$48M
— Key Metrics —
Total Debt$0$0$0$11M$25M
Net Debt-$9M-$8M-$7M$2M$24M
Total Investments$0$843K$489K$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms